Novavax vaccine 96% effective against original coronavirus, 86% for British variant in U.K. trial
The Hindu
Novavax Inc’s coronavirus (COVID-19) vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.
There were no cases of severe illness or deaths among those who got the vaccine.
More Related News